Myovant Stock In The News

MYOV -  USA Stock  

USD 22.27  0.18  0.81%

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Myovant and other traded companies coverage. We help investors stay connected with Myovant headlines for the 22nd of September to make an informed investment decision based on correlating the impacts of news items on Myovant Stock performance. Please note that trading solely based on the Myovant Sciences hype is not for everyone as timely availability and quick action are needed to avoid losses. Net Income Common Stock is likely to drop to about (275.3 M) in 2021.

Search Timeline 

 
Refresh
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Myovant Sciences headlines in addition to utilizing other, more conventional financial analysis modules. Additionally, see Myovant Sciences Backtesting and Myovant Sciences Hype Analysis.
Myovant Sciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Myovant Sciences investors visualize upcoming and past events in order to time the market based on Myovant Sciences noise-free hype analysis.
Myovant Sciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Myovant earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Myovant Sciences that is available to investors today. That information is available publicly through Myovant media outlets and privately through word of mouth or via Myovant internal channels. However, regardless of the origin, that massive amount of Myovant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Myovant Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Myovant Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Myovant Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Myovant Sciences alpha.

Myovant Largest EPS Surprises

Earnings surprises can significantly impact Myovant Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-08-10
2017-06-30-0.29-0.39-0.134 
2017-02-13
2016-12-31-0.2567-0.150.106741 
2017-11-13
2017-09-30-0.3833-0.5-0.116730 
2021-05-11
2021-03-31-1.0206-0.890.130612 
2020-02-10
2019-12-31-0.7771-0.9084-0.131316 
2018-08-07
2018-06-30-0.805-0.98-0.17521 
View All Earnings Estimates

Myovant Sciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Myovant Sciences Stock. Current markets are strongly bullish. About 77% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News
20th of September 2021
Purchase by Sumitomo Chemical Co Ltd of 37913 shares of Myovant Sciences
at MacroaxisInsider 
View Story
S
17th of September 2021
Unclassified Event
at SEC 
View Story
S
16th of September 2021
Purchase by Sumitomo Chemical Co Ltd of 89864 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
Macroaxis News
14th of September 2021
Purchase by Sumitomo Chemical Co Ltd of 30028 shares of Myovant Sciences
at MacroaxisInsider 
View Story
T
13th of September 2021
Exercise or conversion by Terrie Curran of 4850 shares of Myovant Sciences subject to Rule...
at Terrie Curran 
View Story
S
10th of September 2021
Purchase by Sumitomo Chemical Co Ltd of 37000 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
Macroaxis News
9th of September 2021
Myovant Sciences exotic insider transaction detected
at MacroaxisInsider 
View Story
S
8th of September 2021
Purchase by Sumitomo Chemical Co Ltd of 4913 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
S
3rd of September 2021
Purchase by Sumitomo Chemical Co Ltd of 5848 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
Macroaxis News
1st of September 2021
Purchase by Sumitomo Chemical Co Ltd of 000 shares of Myovant Sciences
at MacroaxisInsider 
View Story
A
31st of August 2021
Exercise or conversion by Arjona Ferreira Juan Camilo of 21000 shares of Myovant Sciences ...
at Arjona Ferreira Juan Camilo 
View Story
S
30th of August 2021
Purchase by Sumitomo Chemical Co Ltd of 37038 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
Equities News
27th of August 2021
Myovant gains 5.17 percent on Moderate Volume August 27 - Equities.com
at www.equities.com 
View Story
S
26th of August 2021
Purchase by Sumitomo Chemical Co Ltd of 28709 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
S
24th of August 2021
Purchase by Sumitomo Chemical Co Ltd of 30390 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
Macroaxis News
20th of August 2021
Purchase by Sumitomo Chemical Co Ltd of 46792 shares of Myovant Sciences
at MacroaxisInsider 
View Story
S
18th of August 2021
Purchase by Sumitomo Chemical Co Ltd of 23549 shares of Myovant Sciences
at Sumitomo Chemical Co Ltd 
View Story
Equities News
16th of August 2021
Myovant falls 2.42 percent on Moderate Volume August 16 - Equities.com
at www.equities.com 
View Story
S
12th of August 2021
Filing
at SEC 
View Story
Equities News
3rd of August 2021
Myovant falls 1.29 percent to Close at 20.68 on August 3 - Equities.com
at www.equities.com 
View Story
E
28th of July 2021
EPS Reported
at EPS REPORTED 
View Story
Equities News
26th of July 2021
Myovant Sciences Ltd falls 1.82 percent for July 26 - Equities.com
at www.equities.com 
View Story
Equities News
16th of July 2021
Myovant Sciences Ltd gains 1.46 percent for July 16 - Equities.com
at www.equities.com 
View Story
M
13th of July 2021
Sale by Matthew Lang of 6954 shares of Myovant Sciences
at Matthew Lang 
View Story
A
9th of July 2021
Sale by Arjona Ferreira Juan Camilo of 2777 shares of Myovant Sciences
at Arjona Ferreira Juan Camilo 
View Story
S
7th of July 2021
Other
at SEC 
View Story
E
30th of June 2021
EPS Estimate
at EPS ESTIMATE 
View Story

Be your own money manager

Our tools can tell you how much better you can do entering a position in Myovant Sciences without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Probability Of Bankruptcy Now

   

Probability Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Myovant Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Myovant Sciences Backtesting and Myovant Sciences Hype Analysis. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.